f Stem Cell Nanotechnology Applications as Drug Delivery Systems for Neurodegenerative Disorders

References

1. SamuelP. SundarrajS. SudarmaniD. Nanotechnology-based stem cell therapy: Current status and perspectives.In: Possibilities and limitations in current translational stem cell research.London, UKIntechOpen202310927510.5772/intechopen.109275
   [Google Scholar]
2. RaoM. KhannaA. ShinS. ShinS. Stem cells for the treatment of neurological disorders.CNS Neurol. Disord. Drug Targets2008719810910.2174/187152708783885183 18289036
   [Google Scholar]
3. LindvallO. KokaiaZ. Stem cells for the treatment of neurological disorders.Nature200644170971094109610.1038/nature04960 16810245
   [Google Scholar]
4. LabuscaL. HereaD.D. MashayekhiK. Stem cells as delivery vehicles for regenerative medicine-challenges and perspectives.World J. Stem Cells2018105435610.4252/wjsc.v10.i5.43 29849930
   [Google Scholar]
5. MirP.A. HussainM.S. KhandayA.M. Mohi-ud-dinR. PottooF.H. MirR.H. Immunomodulatory roles of mesenchymal stem cell-derived extracellular vesicles: A promising therapeutic approach for autoimmune diseases.Curr. Stem Cell Res. Ther.2024201410.2174/011574888X341781241216044130 39757602
   [Google Scholar]
6. FrancoisS. MouiseddineM. Allenet-LepageB. Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects.BioMed Res. Int.2013201311410.1155/2013/151679 24369528
   [Google Scholar]
7. JinY. LiS. YuQ. ChenT. LiuD. Application of stem cells in regeneration medicine.MedComm202344e29110.1002/mco2.291 37337579
   [Google Scholar]
8. WuH.H. ZhouY. TabataY. GaoJ-Q. Mesenchymal stem cell-based drug delivery strategy: From cells to biomimetic.J. Cont. Rel.201929410211310.1016/j.jconrel.2018.12.019 30553849
   [Google Scholar]
9. HussainM.S. GuptaG. GhabouraN. Exosomal ncRNAs in liquid biopsies for lung cancer.Clin. Chim. Acta202556511998310.1016/j.cca.2024.119983 39368685
   [Google Scholar]
10. RezaieJ. NejatiV. MahmoodiM. AhmadiM. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system.Biochem. Pharmacol.202220311516710.1016/j.bcp.2022.115167 35820499
    [Google Scholar]
11. FanL. WeiA. GaoZ. MuX. Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy.Biomed. Pharmacoth.202316111445110.1016/j.biopha.2023.114451 36870279
    [Google Scholar]
12. LeeE.J. ChoiY. LeeH.J. HwangD.W. LeeD.S. Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies.J. Nanobiotechnology202220119810.1186/s12951‑022‑01356‑2 35468855
    [Google Scholar]
13. JafariniaM. AlsahebfosoulF. SalehiH. Therapeutic effects of extracellular vesicles from human adipose‐derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis.J. Cell. Physiol.2020235118779879010.1002/jcp.29721 32329062
    [Google Scholar]
14. ChungT.H. HsuS.C. WuS.H. Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson’s disease.Nanoscale20181062998300710.1039/C7NR06976F 29372743
    [Google Scholar]
15. RiazifarM. MohammadiM.R. PoneE.J. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders.ACS Nano20191366670668810.1021/acsnano.9b01004 31117376
    [Google Scholar]
16. MareiH.E. ElnegiryA.A. ZaghloulA. Nanotubes impregnated human olfactory bulb neural stem cells promote neuronal differentiation in Trimethyltin‐induced neurodegeneration rat model.J. Cell. Physiol.2017232123586359710.1002/jcp.25826 28121007
    [Google Scholar]
17. RenH. LiJ. PengA. Water-soluble, alanine-modified fullerene (C60) promotes the proliferation and neuronal differentiation of neural stem cells.Int. J. Mol. Sci.20222310571410.3390/ijms23105714 35628525
    [Google Scholar]
18. FuH. WuY. YangX. Stem cell and its derivatives as drug delivery vehicles: An effective new strategy of drug delivery system.All Life202114178279810.1080/26895293.2021.1967202
    [Google Scholar]
19. MojsilovićS. JaukovićA. KukoljT. Tumorigenic aspects of msc senescence-implication in cancer development and therapy.J. Pers. Med.20211111113310.3390/jpm11111133 34834485
    [Google Scholar]
20. KazmiI. YadavH.K.S. Al-AbbasiF.A. Design of in-situ implant for the brain-targeted drug delivery using cross-linked gellan gum polymer through response surface methodology.Ann. Pharm. Fr.2025831688010.1016/j.pharma.2024.10.004 39419475
    [Google Scholar]
21. HermerénG. Ethical challenges for using human cells in clinical cell therapy.Prog Brain Res2012200174010.1016/B978‑0‑444‑59575‑1.00002‑8 23195413
    [Google Scholar]